GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 114 filers reported holding GOSSAMER BIO INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $354,040 | +735.5% | 300,034 | +546.1% | 0.00% | – |
| Q4 2023 | $42,377 | -76.5% | 46,441 | -69.1% | 0.00% | -100.0% |
| Q2 2023 | $180,076 | -78.3% | 150,063 | -77.3% | 0.00% | -66.7% |
| Q1 2023 | $831,505 | -58.1% | 659,925 | -27.9% | 0.00% | -62.5% |
| Q4 2022 | $1,985,389 | -31.1% | 914,926 | +280.4% | 0.01% | -46.7% |
| Q3 2022 | $2,882,000 | +955.7% | 240,546 | +638.8% | 0.02% | +650.0% |
| Q2 2022 | $273,000 | -38.0% | 32,561 | -35.8% | 0.00% | 0.0% |
| Q1 2022 | $440,000 | +411.6% | 50,747 | +379.9% | 0.00% | – |
| Q2 2021 | $86,000 | -69.2% | 10,575 | -65.0% | 0.00% | -100.0% |
| Q1 2021 | $279,000 | -46.7% | 30,188 | -44.2% | 0.00% | -50.0% |
| Q4 2020 | $523,000 | +195.5% | 54,117 | +278.8% | 0.00% | +100.0% |
| Q3 2020 | $177,000 | -2.2% | 14,286 | +2.8% | 0.00% | -33.3% |
| Q2 2020 | $181,000 | -2.7% | 13,893 | -24.2% | 0.00% | -40.0% |
| Q1 2020 | $186,000 | -64.4% | 18,323 | -45.2% | 0.01% | +66.7% |
| Q4 2019 | $523,000 | – | 33,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |